Better breast cancer screening? iBreast Exam is here

A new product aims to make breast cancer screening available to everyone – even women in low resource settings. The World Health Organization estimates that breast cancer survival rates are below 40% in low-income countries, while it is over 80% in N. America, Sweden and Japan. The difference is due to lack of early detection programs in developing countries. UE Lifesciences  has an answer to this problem: iBreast Exam – a point-of-use wireless scanner that is easy to use, inexpensive and totally portable. It works by assessing differences in tissue elasticity between malignant and non-cancerous breast tissue. The sensors in the hand-held device measure shear stiffness and tissue compression when applied to the skin. Clinical trials in India have produced good results. The award winning company has an infrared scanner for use in conventional clinical settings as well.

We are happy to alert you to products such as iBreast Exam that are examples of innovative and cost-effective medical advances. For more information:

UE Lifesciences website

iBreast Exam website

Clinical trial details

Tell us what you think

This form does not collect your email address. If you would like us to respond, please send questions to
This field is for validation purposes and should be left unchanged.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today